Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Genes & Development|November 16, 2019
Dual functions of angiopoietin-like protein 2 signaling in tumor progression and anti-tumor immunityHaruki Horiguchi, Tsuyoshi Kadomatsu, Ryoma Kurahashi, et al.
Cell Reports|February 13, 2020
A FLCN-TFE3 Feedback Loop Prevents Excessive Glycogenesis and Phagocyte Activation by Regulating Lysosome ActivityMitsuhiro Endoh, Masaya Baba, Tamie Endoh, et al.
Cell Stress & Chaperones|May 19, 2026
Ninth BHD International Symposium: Advancing Research Through Global CollaborationNeil Rajan, Masaya Baba, Andrea Ballabio, et al.
The American Journal of Pathology|June 11, 2025
Folliculin deletion in the mouse kidney results in cystogenesis of the loops of Henle via aberrant TFEB activationOla Shalaby, Tomoko Ohmori, Koichiro Miike, et al.
Cancer Science|April 22, 2019
MicroRNA-204-5p: A novel candidate urinary biomarker of Xp11.2 translocation renal cell carcinomaRyoma Kurahashi, Tsuyoshi Kadomatsu, Masaya Baba, et al.
Genes, Chromosomes & Cancer|March 29, 2002
Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma: relationship to clinicopathological parametersKeiichi Kondo, Masahiro Yao, Minoru Yoshida, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 24, 2009
Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2Yukiko Hasumi, Masaya Baba, Rieko Ajima, et al.
Anticancer Research|August 30, 2023
T1a Renal Cell Carcinoma With Metastasis: Japanese Society of Renal Cancer Retrospective Multi-institute ResultsTaigo Kato, Cong Wang, Naoya Masumori, et al.
Current Issues in Molecular Biology|December 27, 2024
ARID2 Deficiency Enhances Tumor Progression via ERBB3 Signaling in TFE3-Rearranged Renal Cell CarcinomaJinglong Tang, Shintaro Funasaki, Hidekazu Nishizawa, et al.
Pageof 7